TuHURA Biosciences (NASDAQ:HURA) outlined plans for its late-stage immuno-oncology pipeline at the Canaccord Genuity Growth Conference, highlighting an ongoing Phase III study of IFx in first-line advanced Merkel cell carcinoma, a planned AML trial for its VISTA-inhibiting antibody, and preclinical
Comp En De Mn Cemig ADS (NYSE:CIG) reported recurring EBITDA of BRL 2.5 billion for the second quarter of 2026, with recurring EBITDA rising 9.3% from a year earlier and recurring net income increasing 15.6%, according to management during the company’s earnings call.
Chief Executive Officer Alexan
Live Oak Acquisition Corp. V (NASDAQ:TMS), which operates as Teamshares, said it reaffirmed its 2026 outlook and expects acquisitions to be the primary contributor to growth after completing its Nasdaq listing in June.
During its first earnings call as a public company, Teamshares reported that sec
Sigma Lithium (NASDAQ:SGML) reported record second-quarter revenue and profitability as higher production volumes and lower costs supported margins, while the company also addressed a temporary suspension of mining and industrial operations tied to negotiations with the state of Minas Gerais.
Chief
Suncrete (NASDAQ:RMIX) reported sharply higher second-quarter revenue and adjusted EBITDA as the ready-mix concrete and concrete-products company added five acquisitions and expanded its footprint across Sun Belt markets, while maintaining its full-year 2026 outlook.
Revenue rose 146% year over yea
Oncobiologics (NASDAQ:OTLK) said it is preparing for the U.S. commercial launch of LYTENAVA after the Food and Drug Administration approved the product as the only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration, or wet AMD, in the United
CSP (NASDAQ:CSPI) reported lower fiscal third-quarter revenue and a wider net loss as longer hardware delivery times delayed the conversion of orders into revenue, while the company continued to build its managed services business and pursue larger enterprise opportunities for its AZT PROTECT cybers
Sandisk's gross margins hit 85% on fixed-price contracts and AI-driven demand, prompting an Argus upgrade, even as bears question if price-led gains can last.
LanzaTech Global (NASDAQ:LNZA) reported second-quarter 2026 revenue that was broadly flat from a year earlier, while sharply lower operating expenses helped narrow its adjusted EBITDA loss as the company continues shifting from an R&D-led model toward project development and commercialization.
Harmony Biosciences (NASDAQ:HRMY) highlighted record quarterly performance for its narcolepsy treatment WAKIX and outlined development plans across its orexin, epilepsy and pitolisant lifecycle-management programs during Piper Sandler’s virtual CNS Symposium.
Peter Anastasiou, the company’s chief o
Gemini Space Station (NASDAQ:GEMI) reported second-quarter revenue growth despite weaker crypto trading activity, as expanding services revenue, over-the-counter trading and new product offerings offset a decline in exchange revenue. The company also highlighted lower operating costs following restr
